Medical Electronics Symposium 2015
SMTA, INEMI, MEPTEC and OregonBio have joined forces to again host this international conference, focusing on advances in electronic technologies and advanced manufacturing, specifically targeting medical and bioscience applications. Last year’s conference attracted about 200 attendees and more than 30 exhibitors. Prior to last year, MEPTEC's and SMTA's conferences were held in Phoenix, Arizona and Milpitas, CA, respectively, drawing technology experts, entrepreneurs and service providers that work in this niche technology space. Typical applications within this space involve implantable defibrillators, neurostimulators and drug delivery, interventional catheters, pillcams, ultrasound transducers, hearing aids, biosensors, microfluidics, wireless communications, as well as future diagnostic and treatment solutions that may use stretchable electronics, microelectromechanical systems (MEMS) or nanoelectromechanical systems (NEMS).
Submit an abstract!Deadline for submission is August 1, 2015.
View current program here.
Keynote Address: Soft Electronics for the Human BodyJohn A. Rogers, Ph.D., University of Illinois
Recent advances in materials science and mechanical engineering enable construction of high performance optical and electronic microsystems that can flex, bend, fold and stretch, with ability to accommodate large (>>1%) strain deformation with a purely elastic mechanics. Such technologies can be integrated intimately and non-invasively with the surfaces of important organ systems in the human body.
This talk summarizes fundamental and applied aspects of three recent examples that address currently unmet clinical needs:
(1) 'skin-like', wearable electronics for continuous, clinical quality measurements of health status,
(2) high resolution mapping systems capable of resolving fast, transient behaviors in brain activity, and
(3) soft sensors and stimulators for advanced forms of cardiac electrotherapy.
Professor John A. Rogers obtained BA and BS degrees in chemistry and in physics from the University of Texas, Austin, in 1989. From MIT, he received SM degrees in physics and in chemistry in 1992 and the PhD degree in physical chemistry in 1995. From 1995 to 1997, Rogers was a Junior Fellow in the Harvard University Society of Fellows. He joined Bell Laboratories as a Member of Technical Staff in the Condensed Matter Physics Research Department in 1997, and served as Director of this department from the end of 2000 to 2002. He is currently Swanlund Chair Professor at University of Illinois at Urbana/Champaign, with a primary appointment in the Department of Materials Science and Engineering. He is also Director of the Seitz Materials Research Laboratory.
Keynote Address: vBloc Neurometabolic Therapy: Pioneering Micro-electroceutical Treatment of Metabolic DiseaseMark B. Knudson, Ph.D., FAHA, EnteroMedics, Inc.
The concept of treating disease with electroceuticals – using electrons instead of molecules, has gained currency in recent years within the medical, scientific and engineering communities. Early success has come with the application of microelectronic techniques to up-regulating neuromodulation implants, or neurostimulators. Neurostimulation is the therapeutic activation of the nervous system utilizing a pulsed waveform delivered by microelectrodes. A majority of the work being done in the electroceuticals arena has focused on this form of neuromodulation which seeks to increase neurophysiologic activity using low frequency, low amplitude electrical pulse trains. To date this technology has been utilized in the treatment of a number of conditions including hearing loss, epilepsy, pain, and abnormal heart rhythms, to list a few. EnteroMedics’ approach is different from these previous electroceutical neuromodulation devices. vBloc Neurometabolic Therapy has pioneered the blocking part of the neuromodulation spectrum. Rather than increasing neural signals, this therapy interrupts them using a unique algorithm with high frequency, low amplitude waveforms that lead to the blocking of the neurophysiologic transmission on the axon, putting vBloc Neurometabolic Therapy in a neuromodulation category all its own, neuroblocking. Obesity and metabolic disease are an ideal first target for this therapy. By blocking the signals between the gut organs and the brain rather than altering the anatomy, we are offering people with metabolic disease and obesity an option they have not had before – a minimally-invasive, non-anatomy altering solution. vBloc therapy works by controlling hunger and changing a patient’s relationship with food. This presentation will address the development of vBloc Neurometabolic Therapy from scientific concept through a January 2015 FDA approval and its relationship to future trends in this fast-growing field.
Dr. Knudson is Founder, Chairman, President and Chief Executive Officer of EnteroMedics Inc (NASDAQ:ETRM), a position he has held since 2003. He has previously served as managing partner of an early stage venture capital firm and as President of Johnson and Johnson Professional Diagnostics, a Johnson and Johnson Company, following Johnson and Johnson's (NYSE:JNJ) acquisition of Arden Medical Systems, a company he founded in 1983. Subsequently, Dr. Knudson was the founder or involved in the founding of over 20 healthcare companies and successfully exited via acquisitions or initial public offerings (IPO). He held positions in Research and Development management at Cardiac Pacemakers, Inc. (CPI-Guidant) and was a member of the faculty of the University of Washington School of Medicine in Seattle, Washington. He was the recipient of an Individual Post-doctoral Fellowship Award from the National Institutes of Health. Dr. Knudson received the Ph.D. degree (Physiology) from Washington State University and a B.S. degree in biology from Pacific Lutheran University.
Keynote Address: Design Challenges for Home Use Medical DevicesGreg Thompson, VP of Engineering, Sanmina Medical Division
The presentation will cover the challenges that are encountered when taking traditional medical devices and implementing them for the home use environment. The clinical setting is a very controlled environment – this is not true of the home environment. Challenges exist due to foreign substances and rough handling (liquids/dirt/dust, bugs/pests, drop/shock and expected misuse, etc). Challenges also exist due to use by under-trained users – and users that don’t want to admit if the device has experienced accidental abuse.
Greg Thompson is VP of Engineering for Medical Product Design within the Medical Division of Sanmina Corporation. In this roll Mr. Thompson is responsible for all design and development activates associated with the productization of new and improved medical devices and laboratory equipment. The Sanmina Medical Division serves many global customers by designing and manufacturing medical devices for professional use and consumer use. Mr. Thompson has been with Sanmina for more than 30 years in various design and management rolls. Since 2005 Mr. Thompson has managed the medical product design organization at Sanmina. The specific expertise offered by the medical product design team at Sanmina is full turnkey medical device design with compliance to regulatory standards, design controls, risk management, DFx, and supply chain design. Recently a significant focus has been on over the counter consumer medical devices.
Keynote Address: Medical & Healthcare: What are the Opportunities for MEMS and Sensors?Benjamin Roussel, MedTech Activity Lead, Yole Développement
New technologies have the ability to transform healthcare globally: enable early diagnostic through new detection modalities, increase treatment efficiency with targeted drug delivery, and by allowing functions replacements through smart implants surgery.
Due to tremendous potential of the applications, the medical and healthcare markets are nowadays considered by most electronics and semiconductors suppliers as a new growth opportunity. The potential is huge, ranging from high value/high margin medical devices to health consumer products for wellness and fitness.
As part of this market, Wearable electronics is a significantly growing market, mainly driven by smart watches. Many products are already on the market, measuring physical and physiological parameters, which are transferred to a base station (typically a mobile phone). Added value is then created by specific "smart" applications.
To feed these applications with data, the demand for all types of so-called bio-sensors is significantly increasing and affecting the way the sensor industry is organized. Pressure sensors, IR sensors, microfluidic chips, chemical and gas sensors are just few examples. Yole Développement will provide an overview of the applications and the challenges industry will face to enter this market.
Benjamin Roussel is leading the MedTech activity (microfluidic and medical technologies) at Yole Développement. He holds a pharmacy diploma from the University Claude Bernard Lyon, complemented by a master degree in Technology and Innovation Management from EM Lyon Business School.
Come to the MSEI Open HouseSeptember 17, 2015 | 3:00 PM - 5:30 PM
6024 SW Jean Road, Lake Oswego, Oregon (Event held in Bldg A.)
Micro Systems Engineering, Inc. invites you to visit their Lake Oswego campus to learn about implantable electronics products and capabilities. The open house will feature a presentation covering their product line and MST capabilities, followed by factory tours of their electronic module manufacturing facility. Refreshments will be served!
View the flyer for more details. We hope you can join us!
Technical CommitteeGeneral Chair:
Chuck Richardson, iNEMI
Don Banks, St Jude Medical
Track 1 - Components and Designs for High - Density Medical ElectronicsChair:
John McNulty, Exponent Failure Analysis Associates
Dale Lee, Plexus Corp.
Peter Tortorici, Medtronic Microelectronics Center
Cathi Piper, AT&S America LLC
Track 2 - Solutions for Medical Electronics Assembly and Volume ManufacturingChair:
Tony Primavera, Micro Systems Engineering, Inc
Dock Brown, DfR Solutions
Mike Bixenman, Kyzen Corporation
Damon DeSilva, AT&S America LLC
Track 3 - Next Generation Microelectronics for Changing Healthcare MarketsChair:
Fred Sporon-Fiedler, Micro Systems Engineering, Inc
Matt Smits, Oregon Bioscience Association